These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22570918)

  • 1. Welcome to the April '12 issue of Clinical Schizophrenia and Related Psychoses (CS). Introduction.
    Buckley PF
    Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):4. PubMed ID: 22570918
    [No Abstract]   [Full Text] [Related]  

  • 2. Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-78. PubMed ID: 2881965
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for psychotic disorders.
    Treat Guidel Med Lett; 2010 Aug; 8(96):61-4; quiz two pages following last numbered page.. PubMed ID: 20651640
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    PDM; 1974; 5-6(9-12;1-8):10-4. PubMed ID: 4156935
    [No Abstract]   [Full Text] [Related]  

  • 5. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect: effective and free of side effects].
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10 Suppl Schizophre):1-4. PubMed ID: 9828949
    [No Abstract]   [Full Text] [Related]  

  • 6. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.
    Simhandl C; Meszaros K
    J Psychiatry Neurosci; 1992 Mar; 17(1):1-14. PubMed ID: 1349823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New dimensions in the pharmacologic treatment of schizophrenia and related psychoses.
    Buckley PF
    J Clin Pharmacol; 1997 May; 37(5):363-78. PubMed ID: 9156369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic drugs and drugs inducing psychoses].
    Deniker P
    Acta Psychiatr Belg; 1983; 83(3):239-54. PubMed ID: 6138922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern treatment of psychoses?].
    Heinskou T
    Ugeskr Laeger; 2001 May; 163(21):2953-4. PubMed ID: 11402980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Solian: evaluation of 10 years' experimentation and clinical practice].
    Baldauf A; Metzger JY; Sichel JP
    Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.
    Stroup TS; Alves WM; Hamer RM; Lieberman JA
    Nat Rev Drug Discov; 2006 Feb; 5(2):133-46. PubMed ID: 16518380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effects of butyrilperazine].
    Bohacek N
    Neuropsihijatrija; 1964; 12(1-4):133-6. PubMed ID: 16305166
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
    Buckley PF
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic disturbances associated with antipsychotic use.
    Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():3-4; discussion 40-1. PubMed ID: 11806487
    [No Abstract]   [Full Text] [Related]  

  • 18. The CATIE study and its implications for antipsychotic drug use.
    Janicak PG
    Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroprotection: a new strategy in the treatment of schizophrenia. Early detection and intervention.
    Perkins DO
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):10-3. PubMed ID: 19322959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug treatment of functional psychotic disorders].
    Bridler R; Umbricht D; Hell D
    Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.